Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Bioactive Macrocyclic Inhibitors of the PD‐1/PD‐L1 Immune Checkpoint

Open access
Magiera‐Mularz, Katarzyna, Skalniak, Lukasz, Zak, Krzysztof M., Musielak, Bogdan, Rudzinska‐Szostak, Ewa, Berlicki, Łukasz, Kocik, Justyna, Grudnik, Przemyslaw, Sala, Dominik, Zarganes‐Tzitzikas, Tryfon, Shaabani, Shabnam, Dömling, Alexander, Dubin, Grzegorz, Holak, Tad A.·2017·Angewandte Chemie International Edition

Abstract

Blockade of the immunoinhibitory PD‐1/PD‐L1 pathway using monoclonal antibodies has shown impressive results with durable clinical antitumor responses. Anti‐PD‐1 and anti‐PD‐L1 antibodies have now been approved for the treatment of a number of tumor types, whereas the development of small molecules targeting immune checkpoints lags far behind. We characterized two classes of macrocyclic‐peptide inhibitors directed at the PD‐1/PD‐L1 pathway. We show that these macrocyclic compounds act by directly binding to PD‐L1 and that they are capable of antagonizing PD‐L1 signaling and, similarly to antibodies, can restore the function of T‐cells. We also provide the crystal structures of two of these small‐molecule inhibitors bound to PD‐L1. The structures provide a rationale for the checkpoint inhibition by these small molecules, and a description of their small molecule/PD‐L1 interfaces provides a blueprint for the design of small‐molecule inhibitors of the PD‐1/PD‐L1 pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/anie.201707707

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 175

Metadata

Authors
Magiera‐Mularz, K., Skalniak, L., Zak, K. M., Musielak, B., Rudzinska‐Szostak, E., Berlicki, Ł., Kocik, J., Grudnik, P., Sala, D., Zarganes‐Tzitzikas, T., Shaabani, S., Dömling, A., Dubin, G., & Holak, T. A.
Venue
Angewandte Chemie International Edition
Publisher
Wiley
Published
2017-09-26
Volume
56
Issue
44
Pages
13732-13735
ISSN
  • 1433-7851 (ISSN-L)
  • 1521-3773
OpenAlex
W2753716909
Cited by
175
References
2
FWCI
7.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioactive Macrocyclic Inhibitors of the PD‐1/PD‐L1 Immune Checkpoint. https://app.cochat.ai/papers/10.1002/anie.201707707
The paper
Magiera‐Mularz, K., Skalniak, L., Zak, K. M., Musielak, B., Rudzinska‐Szostak, E., Berlicki, Ł., Kocik, J., Grudnik, P., Sala, D., Zarganes‐Tzitzikas, T., Shaabani, S., Dömling, A., Dubin, G., & Holak, T. A. (2017). Bioactive Macrocyclic Inhibitors of the PD‐1/PD‐L1 Immune Checkpoint. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.201707707

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.